NKTR-262
17-262-01
Phase 2 small_molecule terminated
Quick answer
NKTR-262 for Melanoma is a Phase 2 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Melanoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated